Company Filing History:
Years Active: 1998-1999
Title: Innovations by Flavia Arce Mendizabal
Introduction
Flavia Arce Mendizabal is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the efficacy and usability of medications. With a total of two patents to her name, her work focuses on improving the delivery of essential drugs.
Latest Patents
Flavia's latest patents include innovative pharmaceutical formulations of cefaclor and fluoxetine. The cefaclor formulation is designed for the direct-compression manufacture of dispersible tablets. It contains the antibiotic cefaclor in an amount between 35% and 50% by weight of the total weight of the formulation. This formulation is combined with suitable excipients and coadjuvants, such as disintegrators, diluents, lubricants, and flavorings. These tablets are engineered to disintegrate in less than three minutes in water at temperatures between 19°C and 21°C, making them effective for treating infections caused by bacteria strains sensitive to cefaclor.
The fluoxetine formulation also aims to manufacture dispersible tablets through direct compression. It includes the active ingredient fluoxetine or an acid addition salt thereof, along with appropriate excipients and coadjuvants. Similar to the cefaclor formulation, these tablets disintegrate in less than three minutes in water at 19°C to 21°C and are intended for the treatment of depression.
Career Highlights
Flavia Arce Mendizabal is currently associated with Lilly, S.A., a leading pharmaceutical company. Her work at Lilly has allowed her to focus on innovative drug formulations that address critical health issues. Her contributions have been instrumental in advancing the field of pharmaceutical sciences.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Flavia Arce Mendizabal's innovative work in pharmaceutical formulations demonstrates her commitment to improving healthcare solutions. Her patents reflect a deep understanding of drug delivery systems and their impact on patient care.